Thrombotic complications may occur early after marrow transplantation
and many data suggest that endothelial injury plays a pivotal role in
their pathogenesis. Since plasma thrombomodulin and P-selectin are tho
ught to be of value as markers of vascular endothelial cell membrane i
njury, we investigated their plasma concentration in bone marrow trans
plant patients aiming better to clarify the degree of endothelial invo
lvement. Plasma thrombomodulin and P-selectin were monitored in 25 pat
ients without thrombotic complications before transplant, on day 0 and
weekly for 1 month thereafter, while in three patients who developed
VOD monitoring continued until day +52. These proteins were in the nor
mal range in all the uncomplicated patients and in two with reversible
VOD, while they were always very high in the only patient who develop
ed very severe and lethal VOD, In conclusion, we suggest that endothel
ial activation/damage occurs rarely in the course of BMT for hematolog
ical malignancies; we were able to document endothelial injury in only
one patient with very severe thrombotic complication.